Milgamma Mono 150 (Benfotiamine)

Benfotiamine is a vitamin B1 derivative that acts on metabolic pathways and peripheral nerve health. It is employed in the following clinical situations:

• Diabetic peripheral neuropathy: helps alleviate nerve pain and sensory deficits associated with long‑term diabetes.
• Alcohol‑induced neuropathy: supports nerve regeneration and reduces tingling sensations caused by chronic alcohol use.
• General thiamine deficiency: restores normal carbohydrate metabolism when dietary intake of vitamin B1 is insufficient.

• Benfotiamine is a lipophilic pro‑drug of thiamine that readily crosses cell membranes. Once inside cells, it is converted to thiamine pyrophosphate, the active co‑factor for enzymes involved in glucose metabolism, such as transketolase. By enhancing intracellular thiamine levels, it supports the pentose‑phosphate pathway, reduces accumulation of advanced glycation end‑products, and promotes normal nerve function.

Benfotiamine is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects

• Nausea: mild stomach upset after ingestion.
• Headache: transient mild headache.
• Diarrhea: loose stools in sensitive individuals.
• Skin rash: mild erythema or itching.
• Dizziness: occasional light‑headed feeling.

Serious or Rare Side Effects

• Hypersensitivity reaction: swelling, hives, or difficulty breathing.
• Severe skin eruption: Stevens‑Johnson‑like rash.
• Hepatic enzyme elevation: abnormal liver function tests.
• Anaphylaxis: rapid onset of severe allergic response.

Before using Benfotiamine, consider the following safety measures.

• Renal function assessment: adjust use if severe kidney impairment is present.
• Blood glucose monitoring: observe for unexpected changes in diabetic patients.
• Pregnancy and lactation: use only if clearly needed, as safety data are limited.
• Known hypersensitivity: avoid if allergic to benfotiamine or related thiamine compounds.
• Dosage adherence: do not exceed the prescriber's recommendation.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Benfotiamine may interact with certain medicines; awareness helps prevent issues.

Major Interactions (Avoid)

• None identified: no major drug‑drug interactions have been reported for benfotiamine.

Moderate Interactions (Monitor Closely)

• Alcohol: concurrent use may diminish the supplement’s nerve‑protective effect.
• Diuretics: may increase urinary thiamine loss, potentially reducing efficacy.
• Anticonvulsants (e.g., phenobarbital): can accelerate thiamine metabolism, requiring closer monitoring.
• Chemotherapeutic agents: theoretical risk of altered vitamin metabolism; monitor nutritional status.